E-LIB Suche - Ergebnisse für: Durigutto, Paolo

1

A novel complement-fixing IgM antibody targeting GPC1 as a ..:

Busato, Davide ; Capolla, Sara ; Durigutto, Paolo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685509/. , 2023

Link: http://www.ncbi.nlm.nih...

2

Plasminogen activator-coated nanobubbles targeting cell-bou..:

Macor, Paolo ; Durigutto, Paolo ; Argenziano, Monica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316273/. , 2022

Link: http://www.ncbi.nlm.nih...

3

Multiple-Organ Complement Deposition on Vascular Endotheliu..:

Macor, Paolo ; Durigutto, Paolo ; Mangogna, Alessandro...
info:eu-repo/semantics/altIdentifier/wos/WOS:000688776400001. , 2021

Link: http://hdl.handle.net/11..

4

Multi-organ complement deposition in COVID-19 patients:

Macor, Paolo ; Durigutto, Paolo ; Mangogna, Alessandro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805461/. , 2021

Link: http://www.ncbi.nlm.nih...

5

Complement activation and thrombin generation by MBL bound ..:

Durigutto, Paolo ; Macor, Paolo ; Pozzi, Nicola...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489996/. , 2020

Link: http://www.ncbi.nlm.nih...

6

New insight into antiphospholipid syndrome: antibodies to β..:

Durigutto, Paolo ; Grossi, Claudia ; Borghi, Maria Orietta...
info:eu-repo/semantics/altIdentifier/pmid/30442725. , 2019

Link: http://hdl.handle.net/11..

7

Targeted Delivery of Neutralizing Anti-C5 Antibody to Renal..:

Durigutto, Paolo ; Sblattero, Daniele ; Biffi, Stefania...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592221/. , 2017

Link: http://www.ncbi.nlm.nih...

8

Targeted delivery of neutralizing anti-C5 antibody to renal..:

DURIGUTTO, PAOLO ; SBLATTERO, DANIELE ; BIFFI, STEFANIA...
info:eu-repo/semantics/altIdentifier/pmid/28932227. , 2017

Link: http://hdl.handle.net/11..

9

C1q acts in the tumour microenvironment as a cancer-promoti..:

BULLA, ROBERTA ; RAMI, DAMIANO ; ZORZET, SONIA...
info:eu-repo/semantics/altIdentifier/pmid/26831747. , 2016

Link: http://hdl.handle.net/11..

10

Complement activation in antiphospholipid syndrome and its ..:

Meroni, Pier Luigi ; De Maso, Luca ; Gerosa, Maria...
info:eu-repo/semantics/altIdentifier/pmid/26644452. , 2016

Link: http://hdl.handle.net/11..

11

Bispecific antibodies targeting tumor-associated antigens a..:

MACOR, PAOLO ; MEZZAROBA, NELLY ; ZORZET, SONIA...
info:eu-repo/semantics/altIdentifier/pmid/24903480. , 2015

Link: http://hdl.handle.net/11..

12

Critical role and therapeutic control of the lectin pathway..:

Petitbarat, Marie ; Palmioli, Alessandro ; Bernardi, Anna...
info:eu-repo/semantics/altIdentifier/pmid/26561549. , 2015

Link: http://hdl.handle.net/11..

13

In vivo distribution of beta 2 glycoprotein I under various..:

Agostinis, Chiara ; BİFFİ, Stefania ; GARROVO, Chiara...
Agostinis C., BİFFİ S., GARROVO C., DURİGUTTO P., LORENZON A., Bek A., Bulla R., Grossi C., Borghi M. O. , Meroni P., et al., "In vivo distribution of beta 2 glycoprotein I under various pathophysiologic conditions", BLOOD, cilt.118, ss.4231-4238, 2011. , 2011

Link: https://hdl.handle.net/1..

14

In vivo distribution of beta 2 glycoprotein I under various..:

Agostinis, Chiara ; BİFFİ, Stefania ; GARROVO, Chiara...
Agostinis C., BİFFİ S., GARROVO C., DURİGUTTO P., LORENZON A., Bek A., Bulla R., Grossi C., Borghi M. O. , Meroni P., et al., "In vivo distribution of beta 2 glycoprotein I under various pathophysiologic conditions", BLOOD, cilt.118, ss.4231-4238, 2011. , 2011

Link: https://hdl.handle.net/1..

15

Novel pathogenic mechanism and therapeutic approaches to an..:

Bossi, Fleur ; Fischetti, Fabio ; Regoli, Domenico...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798851. , 2009

Link: http://www.ncbi.nlm.nih...